As expected volume indicated an announcement was expected for BDA since last friday.
Its been a rough couple of months for the whole medical cannabis sector correction around the world.
Strong support at ~35c and I believe due to BDAs valuations being the lowest of all the MM sector, given enough time to progress and commercialise. BDA to outperform from here onwards in 2018